Deep-dive AI research reports on individual stocks, powered by our proprietary signals. Every report carries a direction (Bullish or Bearish) and a conviction level(Strong or Speculative). We track stock performance since each report's publication date — because we believe great analysis should be held accountable.

The Invisible Hand Strangling ZYME's Shorts: A Deep Dive into Biotech's Quietest Squeeze

2026-04-16BullishStrongChange from report: -6.9%1M: -10.2%3M: -11.1%

ZYME's stock surge is driven by a hidden institutional squeeze, not just positive news. Data shows massive off-exchange buying overpowering short sellers, forcing a capitulation.